Back number 2018
November 29, 2018
Group to take comprehensive range of portfolio, efficiency and structural measures

Bayer to strengthen core life science businesses while significantly enhancing productivity and profitability

Read more
November 13, 2018
Third quarter of 2018

Bayer: Good performance in a challenging environment, Group outlook confirmed

Read more
September 05, 2018
Second quarter of 2018

Bayer completes biggest acquisition in its history

Read more
August 16, 2018
Following completion of the divestment of Crop Science businesses to BASF

Bayer: Conditions for beginning Monsanto integration fulfilled

Read more
July 31, 2018

LEO Pharma to expand its lead in medical dermatology with acquisition of Bayer’s prescription dermatology unit

Read more
June 07, 2018

Bayer closes Monsanto acquisition

Read more
June 04, 2018

Bayer plans closing of Monsanto acquisition on June 7

Read more
May 29, 2018

U. S. Department of Justice conditionally approves
Bayer’s proposed acquisition of Monsanto

Read more
May 03, 2018
First quarter of 2018

Bayer: Operational business held back by currency effects - Major progress with Monsanto acquisition

Read more
April 26, 2018
Issues raised by regulatory authorities in respect of Monsanto acquisition addressed:

Bayer signs agreement to sell further Crop Science businesses to BASF for up to 1.7 billion euros

Read more